| Product Name | Pirfenidone (AMR69) |
|---|---|
| CAS | 53179-13-8 |
| Formula | C12H11NO |
| MW | 197.33 |
| Appearance | White to light yellow powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 500 mg | In-stock | $126.00 | Visible after login | |
| 1 g | In-stock | $168.00 | Visible after login |
| Product Name | Pirfenidone (AMR69) |
|---|---|
| CAS | 53179-13-8 |
| Formula | C12H11NO |
| MW | 197.33 |
| Appearance | White to light yellow powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Pirfenidone is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF). It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II. Pirfenidone has well-established antifibrotic and anti-inflammatory properties in various in vitro systems and animal models of fibrosis. A number of cell-based studies have shown that pirfenidone reduces fibroblast proliferation, inhibits TGF-β stimulated collagen production and reduces the production of fibrogenic mediators such as TGF-β.